Michael Robin Witt
Director Ejecutivo en GABATHER AB .
Cargos activos de Michael Robin Witt
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| GABATHER AB | Director/Miembro de la Junta | 01/09/2014 | - |
| Director Ejecutivo | 01/10/2018 | - | |
| Contacto de Relaciones con Inversores | - | - | |
| Lead Discovery Malaysia Sdn. Bhd. | Director Ejecutivo | 01/01/2012 | - |
| Director Técnico/Científico/I+D | 01/01/2012 | - |
Historial de carrera de Michael Robin Witt
Antiguos cargos conocidos de Michael Robin Witt.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Axcentua Pharmaceuticals AB
 Axcentua Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Axcentua Pharmaceuticals AB develops anti-cancer drugs for pancreatic cancer patients. It generates investigational new drugs for diseases with unmet medical need in Sweden. The firm offers AXP107-11, multi-targeted chemosensitizer and a small-molecule anti-cancer compound for the treatment of various solid tumors, such as non-small cell lung cancers. The company was founded in 2007 by Anders Berkenstam, Stefan Rehnmark and Michael-Robin Witt and is headquartered in Stockholm, Sweden. | Director Técnico/Científico/I+D | 01/09/2010 | 01/04/2012 |
| Fundador | 01/01/2007 | 01/04/2012 | |
| KARO PHARMA AB (PUBL) | Director Técnico/Científico/I+D | 01/01/2002 | - |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Corporate Officer/Principal | - | - |
| NTG NORDIC TRANSPORT GROUP A/S | Corporate Officer/Principal | - | - |
Formación de Michael Robin Witt.
| Vrije Universiteit Brussel | Doctorate Degree |
| Danmarks Farmaceutiske Universitet | Doctorate Degree |
Estadísticas
Internacional
| Suecia | 5 |
| Dinamarca | 3 |
| Bélgica | 2 |
Operativa
| Chief Tech/Sci/R&D Officer | 3 |
| Doctorate Degree | 2 |
| Corporate Officer/Principal | 2 |
Sectorial
| Health Technology | 4 |
| Consumer Services | 3 |
| Transportation | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| NTG NORDIC TRANSPORT GROUP A/S | Transportation |
| KARO PHARMA AB (PUBL) | Health Technology |
| GABATHER AB | Health Technology |
| Empresas privadas | 3 |
|---|---|
Axcentua Pharmaceuticals AB
Axcentua Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Axcentua Pharmaceuticals AB develops anti-cancer drugs for pancreatic cancer patients. It generates investigational new drugs for diseases with unmet medical need in Sweden. The firm offers AXP107-11, multi-targeted chemosensitizer and a small-molecule anti-cancer compound for the treatment of various solid tumors, such as non-small cell lung cancers. The company was founded in 2007 by Anders Berkenstam, Stefan Rehnmark and Michael-Robin Witt and is headquartered in Stockholm, Sweden. | Health Technology |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
| Lead Discovery Malaysia Sdn. Bhd. |
- Bolsa de valores
- Insiders
- Michael Robin Witt
- Experiencia
